Enanta (ENTA) Stock Performance – 24‑Hour Summary
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) experienced a 2.28 % increase in its share price during the 24‑hour period concluding at 10:34 PM Central Europe on Wednesday, 21 March 2026. At the close, the stock traded at approximately USD 11.31 on major exchanges.
- Current Market Capitalization: USD 332.3 million
- Outstanding Shares: 29.1 million
- Volume Traded (Last 24 hrs): USD 1.9 million worth of shares
- Year‑to‑Date Change (Since Last Month End): –3.63 %
- 200‑Day Simple Moving Average: USD 13.27
- 52‑Week High: USD 17.15 (recorded 29 December 2025)
- 52‑Week Low: USD 10.20 (recorded 23 October 2025)
Related Stock Movements – Last 24 Hours
| Symbol | Company | 24‑Hour Move | Current Price | Market Cap | Notable Events |
|---|---|---|---|---|---|
| VGZ | Vista Gold Corp. | 0 % | USD 2.77 | USD 397 million | Planned share‑exchange arrangement with Artemis Gold Inc. Requires shareholder approval at a special meeting; completion targeted Q1 2027. |
| ZKP | Lafayette Digital Acquisition | +0.2 % | USD 10.05 | USD 392.1 million | — |
| ISTR | Investar | +0.24 % | USD 28.74 | USD 393.8 million | P/E ratio: 11.57 |
| MAGN | Magnera | +1 % | USD 11.20 | USD 392.4 million | — |
| TACO | Berto Acquisition | –0.04 % | USD 10.48 | USD 393.2 million | — |
Company Profile – Enanta Pharmaceuticals
Enanta Pharmaceuticals, Inc. is a biotechnology company focused on the research, development, and production of small‑molecule drugs for viral infections and liver diseases. The company serves patients and customers within the United States. Enanta is listed on the Nasdaq stock exchange and completed its initial public offering on 21 March 2013. The company’s corporate information and updates are available at www.enanta.com .